A Pilot Study of Differentiation Therapy in Multiple Myeloma Using Interleukin-6 and Interferon-a.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha; Interleukin-6
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2018 Biomarkers information updated
- 24 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.